JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Association between patient medications and postoperative outcomes in early-stage non-small cell lung cancer

  • 0Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Journal of Thoracic Disease +

|

November 18, 2024

|

November 18, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

The number of prescription medications before surgery is linked to worse outcomes in early-stage non-small cell lung cancer (NSCLC) patients. More medications, especially for respiratory and nervous systems, increase the risk of complications and reduce overall survival.

Area Of Science

  • Oncology
  • Pharmacology
  • Health Services Research

Background

  • Assessing comorbidities in lung cancer patients lacks a standardized clinical approach.
  • Prescription medication data offers a potential tool for comorbidity assessment and predicting surgical outcomes.
  • The study focuses on early-stage non-small cell lung cancer (NSCLC) to examine this relationship.

Purpose Of The Study

  • To investigate the association between preoperative prescription medication use and postoperative outcomes in early-stage NSCLC patients.
  • To determine if the number and type of medications correlate with adverse events and overall survival.
  • To evaluate the utility of prescription data as a comorbidity assessment tool in this population.

Main Methods

  • A retrospective cohort study of 9,741 veterans with clinical stage I NSCLC undergoing surgical resection.
  • Analysis of outpatient prescriptions filled within one year prior to surgery, categorized by Anatomical Therapeutic Chemical (ATC) Level One.
  • Assessment of the link between medication use and 30/90-day postoperative adverse events (death or major complications) and overall survival.

Main Results

  • A higher number of prescription medications was associated with increased risk of 30-day and 90-day postoperative adverse events.
  • Increased medication use also correlated with decreased overall survival (OS).
  • Patients using respiratory or nervous system medications showed elevated risks for postoperative adverse events.

Conclusions

  • Preoperative medication count is a significant predictor of short- and long-term postoperative outcomes in early-stage NSCLC.
  • Specific medication classes, particularly those for respiratory and nervous systems, heighten the risk of adverse events.
  • Prescription medication data serves as a valuable tool for assessing comorbidities and perioperative risk in NSCLC patients.

Keywords: